Literature DB >> 9625835

Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: correlation with clinicopathologic features and tumor markers.

H Shimada1, K Nakajima, T Ochiai, Y Koide, S I Okazumi, H Matsubara, A Takeda, Y Miyazawa, M Arima, K Isono.   

Abstract

The significance of serum p53-Abs in patients with esophageal squamous cell carcinoma was determined. Examination of clinicopathological features and assessment of tumor marker sensitivities of carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC-Ag) and CYFRA21-1 were performed. Thirty-three (58%) of 57 patients were positive for serum p53-Abs, however, no relation with cancer progression existed. Fourteen of the 33 sero-positive patients revealed normal levels of all tumor markers tested. Thus, serum p53-Abs appears to be a useful marker for the detection of esophageal squamous cell carcinoma.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9625835     DOI： 10.3892/or.5.4.871

Source DB:  PubMed          Journal:  Oncol Rep        ISSN： 1021-335X            Impact factor:   3.906


  9 in total

1.  Clinical significance of serum anti-p53 antibody expression following curative surgery for colorectal cancer.

Authors:  Kensuke Kumamoto; Hideyuki Ishida; Koki Kuwabara; Kunihiko Amano; Noriyasu Chika; Norimichi Okada; Tomonori Ohsawa; Youichi Kumagai; Keiichiro Ishibashi
Journal:  Mol Clin Oncol       Date:  2017-08-08

Review 2.  Serum autoantibodies in the early detection of esophageal cancer: a systematic review.

Authors:  Hongfei Zhang; Junfen Xia; Kaijuan Wang; Jianying Zhang
Journal:  Tumour Biol       Date:  2014-11-30

3.  Usefulness of serum p53 antibody measurement in colorectal cancer: an examination of 1384 primary colorectal cancer patients.

Authors:  Tetsuji Yamaguchi; Yasumasa Takii; Satoshi Maruyama
Journal:  Surg Today       Date:  2013-08-23       Impact factor: 2.549

4.  Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma.

Authors:  Akiko Kagaya; Hideaki Shimada; Tooru Shiratori; Mari Kuboshima; Kazue Nakashima-Fujita; Mari Yasuraoka; Takanori Nishimori; Shunsuke Kurei; Takahisa Hachiya; Akihiro Murakami; Yutaka Tamura; Fumio Nomura; Takenori Ochiai; Hisahiro Matsubara; Masaki Takiguchi; Takaki Hiwasa
Journal:  Proteome Sci       Date:  2011-06-23       Impact factor: 2.480

5.  Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers.

Authors:  Junko Umeda; Takao Itoi; Atsushi Sofuni; Fumihide Itokawa; Toshio Kurihara; Takayoshi Tsuchiya; Kentaro Ishii; Shujiro Tsuji; Nobuhito Ikeuchi; Reina Tanaka; Ryosuke Tonozuka; Mitsuyoshi Honjo; Shuntaro Mukai; Toshitaka Nagao; Hisashi Oshiro; Fuminori Moriyasu
Journal:  J Oncol       Date:  2013-12-18       Impact factor: 4.375

6.  Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.

Authors:  Shu-Yang Li; Yoichi Yoshida; Eiichi Kobayashi; Akihiko Adachi; Seiichiro Hirono; Tomoo Matsutani; Seiichiro Mine; Toshio Machida; Mikiko Ohno; Eiichiro Nishi; Yoshiro Maezawa; Minoru Takemoto; Koutaro Yokote; Kenichiro Kitamura; Makoto Sumazaki; Masaaki Ito; Hideaki Shimada; Hirotaka Takizawa; Koichi Kashiwado; Go Tomiyoshi; Natsuko Shinmen; Rika Nakamura; Hideyuki Kuroda; Xiao-Meng Zhang; Hao Wang; Kenichiro Goto; Yasuo Iwadate; Takaki Hiwasa
Journal:  Int J Mol Med       Date:  2020-07-29       Impact factor: 4.101

Review 7.  Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.

Authors:  Yi-Wei Xu; Yu-Hui Peng; Li-Yan Xu; Jian-Jun Xie; En-Min Li
Journal:  World J Gastroenterol       Date:  2019-09-14       Impact factor: 5.742

Review 8.  Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.

Authors:  Ling-Yu Chu; Yu-Hui Peng; Xue-Fen Weng; Jian-Jun Xie; Yi-Wei Xu
Journal:  World J Gastroenterol       Date:  2020-04-21       Impact factor: 5.742

9.  Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma.

Authors:  Hideaki Shimada; Tooru Shiratori; Mari Yasuraoka; Akiko Kagaya; Mari Kuboshima; Fumio Nomura; Masaki Takiguchi; Takenori Ochiai; Hisahiro Matsubara; Takaki Hiwasa
Journal:  BMC Cancer       Date:  2009-07-15       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.